Business

Ultragenyx reports Phase 3 results for setrusumab in OI, plans expense reductions

Dec 29, 2025 - 14:00
 0
Ultragenyx reports Phase 3 results for setrusumab in OI, plans expense reductions
Read More

Related Posts

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025  2

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025  5

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025  1

Factbox-What fighter jet programs does the US Air Force have?

Factbox-What fighter jet programs does the US Air Force...

Mar 21, 2025  2

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

Mar 21, 2025  0